[{"orgOrder":0,"company":"San Diego Veterans Healthcare System","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Miscellaneous","year":"2025","type":"Inapplicable","leadProduct":"Bismuth","moa":"Serum albumin (ALB)","graph1":"Infections and Infectious Diseases","graph2":"Phase III","graph3":"San Diego Veterans Healthcare System","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"San Diego Veterans Healthcare System \/ Undisclosed","highestDevelopmentStatusID":"10","companyTruncated":"San Diego Veterans Healthcare System \/ Undisclosed"}]

Find Clinical Drug Pipeline Developments & Deals for Bismuth

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          San Diego Veterans Healthcare System

                          Country arrow
                          FNCE
                          Not Confirmed

                          San Diego Veterans Healthcare System

                          Country arrow
                          FNCE
                          Not Confirmed

                          Details : Bismuth is a Other Small Molecule drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Helicobacter Infections.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          August 05, 2025

                          Lead Product(s) : Bismuth

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase III

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank